Resonate Blends (KOAN) Stock Price & Analysis
KOAN Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- $0.01 - $0.02
- Previous Close
- $0.01
- Volume
- 3.80M
- Average Volume (3M)
- 3.39M
- Market Cap
- $182.73K
- Enterprise Value
- $5.86T
- Total Cash (Recent Filing)
- $216.90K
- Total Debt (Recent Filing)
- $5.92M
- Price to Earnings (P/E)
- ―
- Beta
- -0.15
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
KOAN FAQ
What was Resonate Blends’s price range in the past 12 months?
What is Resonate Blends’s market cap?
When is Resonate Blends’s upcoming earnings report date?
Is Resonate Blends overvalued?
Does Resonate Blends pay dividends?
What is Resonate Blends’s EPS estimate?
How many shares outstanding does Resonate Blends have?
Which hedge fund is a major shareholder of Resonate Blends?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Resonate Blends
APOLLO BioWellness Inc. focuses its efforts on researching, formulating, and bringing to market products designed for human health within the regenerative medicine sector. A significant part of its operations involves the commercialization of licensed, naturally derived compounds currently awaiting patent approval, which are specifically engineered to boost an individual's innate capacity to mobilize adult stem cells from their own bone marrow. Additionally, the firm possesses the marketing rights for an all-natural, two-pronged dietary supplement crafted to help regulate hunger by engaging the body's intrinsic signaling pathways between the brain and the digestive system. Beyond its current offerings, the company is also deeply involved in research and development initiatives. These efforts are dedicated to exploring new frontiers, such as Secretogues aimed at enhancing a person's endogenous growth hormone synthesis, along with other natural bioactive formulations intended to optimize human physiological performance. This is achieved by harnessing the body's own biological mechanisms, entirely without the use of pharmaceutical drugs. The company maintains its corporate headquarters in North Bergen, New Jersey.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- James W. Zimbler
- Employees
- 2
- Website
- www.apollobiowellness.com
- Address
- One Marine Plaza, North Bergen, NJ, 04047, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 1 | 5 |
| Technical Analysis | 3 | 1 | 1 |
| Moving Averages | 0 | 0 | 4 |


